|
C18ORF54 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.02009994790353E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.79669978684194E-10 |
| Normal-vs-Stage2 |
2.842500E-03 |
| Normal-vs-Stage3 |
3.605600E-04 |
| Normal-vs-Stage4 |
1.68856999999134E-05 |
| Stage1-vs-Stage2 |
7.663800E-01 |
| Stage1-vs-Stage3 |
2.026200E-02 |
| Stage1-vs-Stage4 |
5.126600E-01 |
| Stage2-vs-Stage3 |
3.504600E-01 |
| Stage2-vs-Stage4 |
9.139200E-01 |
| Stage3-vs-Stage4 |
2.081800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.96600000115887E-09 |
| Normal-vs-AfricanAmerican |
2.795600E-03 |
| Normal-vs-Asian |
1.634940E-04 |
| Caucasian-vs-AfricanAmerican |
3.256600E-01 |
| Caucasian-vs-Asian |
1.726950E-01 |
| AfricanAmerican-vs-Asian |
8.348100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.81700029758758E-10 |
| Normal-vs-Female |
1.59967999999733E-05 |
| Male-vs-Female |
6.752300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.192900E-04 |
| Normal-vs-Age(41-60Yrs) |
9.69239999371041E-09 |
| Normal-vs-Age(61-80Yrs) |
1.25250000038157E-07 |
| Normal-vs-Age(81-100Yrs) |
3.160800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.973040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.543900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.658400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.706000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.696600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.838100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.009500E-04 |
| Normal-vs-Grade 2 |
6.75569600261383E-11 |
| Normal-vs-Grade 3 |
1.87106999999243E-05 |
| Normal-vs-Grade 4 |
8.846700E-04 |
| Grade 1-vs-Grade 2 |
7.198800E-01 |
| Grade 1-vs-Grade 3 |
3.184300E-02 |
| Grade 1-vs-Grade 4 |
2.289000E-01 |
| Grade 2-vs-Grade 3 |
3.378300E-04 |
| Grade 2-vs-Grade 4 |
8.488200E-02 |
| Grade 3-vs-Grade 4 |
5.927200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.05840019976245E-10 |
| Normal-vs-ccB subtype |
1.5804699999955E-05 |
| ccA subtype-vs-ccB subtype |
7.256200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.74709999987289E-08 |
| Normal-vs-N1 |
2.483700E-02 |
| N0-vs-N1 |
6.524400E-01 |
|
|
